STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
STAT [Unofficial]
March 24, 2026
In today's Readout newsletter: Gilead to acquire an immunology biotech and Merck partners with Flagship company on IBD targets. Plus: Do you have what it takes to be CBER director?
Discussion in the ATmosphere